Constructing a cell line-based treatment model for pancreatic adenocarcinoma patients receiving first-line second-line chemotherapies: a novel method in preclinical study
Objective: Approximately 80% of patients with pancreatic adenocarcinoma (PA) are diagnosed with locally advanced, unresectable, or metastatic disease at presentation. First-, second-, and third-line chemotherapies are beneficial for patients. Gemcitabine (GEM)-based regimens played an indispensable...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Verduci Editore
2024-09-01
|
| シリーズ: | World Cancer Research Journal |
| 主題: | |
| オンライン･アクセス: | https://www.wcrj.net/wp-content/uploads/sites/5/2024/09/e2835.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|